FDA.reportPublic FDA data

Application 077437

Type
ANDA
Sponsor
TEVA PHARMS USA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001MOXIFLOXACIN HYDROCHLORIDEMOXIFLOXACIN HYDROCHLORIDETABLET;ORALEQ 400MG BASENoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0093-7387Moxifloxacin HydrochlorideMoxifloxacin HydrochlorideTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7387Moxifloxacin HydrochlorideMoxifloxacin HydrochlorideTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7387Moxifloxacin HydrochlorideMoxifloxacin HydrochlorideTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7387Moxifloxacin HydrochlorideMoxifloxacin HydrochlorideTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7387Moxifloxacin HydrochlorideMoxifloxacin HydrochlorideTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7387Moxifloxacin HydrochlorideMoxifloxacin HydrochlorideTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7387Moxifloxacin HydrochlorideMoxifloxacin HydrochlorideTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7387Moxifloxacin HydrochlorideMoxifloxacin HydrochlorideTeva Pharmaceuticals USA, Inc.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
9045ORIG2014-02-20